Wiegand, Susanna

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

MAGIC, Speliotes, E. K., on behalf of Procardis Consortium, Willer, C. J., Berndt, S. I., Monda, K. L., Thorleifsson, G., Jackson, A. U., Allen, H. L., Lindgren, C. M., et al. (2010) · Nature Genetics

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 2,912

Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: Single-arm, open-label, multicentre, phase 3 trials

Clément, K., van den Akker, E., Argente, J., Bahm, A., Chung, W. K., Connors, H., De Waele, K., Farooqi, I. S., Gonneau-Lejeune, J., Gordon, G., et al. (2020) · The Lancet Diabetes & Endocrinology

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 492

Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist

Kühnen, P., Clément, K., Wiegand, S., Blankenstein, O., Gottesdiener, K., Martini, L. L., Mai, K., Blume-Peytavi, U., Grüters, A., & Krude, H. (2016) · New England Journal of Medicine

Regulation of Appetite and ObesityAdrenal Hormones and Disorders

Cited by 485

Current guidelines for obesity prevention in childhood and adolescence

Weihrauch-Blüher, S., Kromeyer-Hauschild, K., Graf, C., Widhalm, K., Korsten-Reck, U., Jödicke, B., Markert, J., Müller, M. J., Moss, A., Wabitsch, M., et al. (2018) · Obesity Facts

Obesity, Physical Activity, DietObesity and Health Practices

Cited by 186

Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis

Mohs, A., Otto, T., Schneider, K. M., Peltzer, M., Boekschoten, M., Holland, C. H., Hudert, C. A., Kalveram, L., Wiegand, S., Saez-Rodriguez, J., et al. (2021) · Journal of Hepatology

Genomics, phytochemicals, and oxidative stressLiver Disease Diagnosis and Treatment

Cited by 137

Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency

Neumann, U., Whitaker, M. J., Wiegand, S., Krude, H., Porter, J., Davies, M., Digweed, D., Voet, B., Ross, R. J., & Blankenstein, O. (2018) · Clinical Endocrinology

Adrenal Hormones and DisordersPharmaceutical studies and practices

Cited by 64

Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines

Reinehr, T., Karges, B., Meissner, T., Wiegand, S., Stoffel-Wagner, B., Holl, R. W., & Woelfle, J. (2016) · The Journal of Pediatrics

Adipokines, Inflammation, and Metabolic DiseasesSkin Diseases and Diabetes

Cited by 51

A prospective study of children aged 0–8 years with cah and adrenal insufficiency treated with hydrocortisone granules

Neumann, U., Braune, K., Whitaker, M. J., Wiegand, S., Krude, H., Porter, J., Digweed, D., Voet, B., Ross, R. J. M., & Blankenstein, O. (2021) · The Journal of Clinical Endocrinology & Metabolism

Adrenal Hormones and DisordersSexual Differentiation and Disorders

Cited by 38

Reduced 11β-hydroxysteroid dehydrogenase type 1 activity in obese boys

Wiegand, S., Richardt, A., Remer, T., Wudy, S. A., Tomlinson, J. W., Hughes, B., Grüters, A., Stewart, P. M., Strasburger, C. J., & Quinkler, M. (2007) · European Journal of Endocrinology

Adrenal Hormones and DisordersHormonal Regulation and Hypertension

Cited by 37

Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database

Awa, W. L., Schober, E., Wiegand, S., Herwig, J., Meissner, T., Schmidt, F., Molz, E., & Holl, R. W. (2011) · Diabetes Research and Clinical Practice

Diabetes and associated disordersDiabetes Management and Research

Cited by 35